[Therapy using cytostatics. Desired and undesired effects].
D000014:Abnormalities, Drug-Induced; D000505:Alopecia / Q000139:chemically induced; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D001943:Breast Neoplasms / Q000188:drug therapy; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002455:Cell Division / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007165:Immunosuppression Therapy; D007938:Leukemia / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D009154:Mutation / Q000187:drug effects; D009369:Neoplasms / Q000139:chemically induced; D013736:Testicular Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents
Zytostatika-Therapie. Erwünschte und unerwünschte Wirkungen.